Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients.

Literature DB >> 23902281

Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients.

A Schmidt-Tanguy¹, J Voswinkel, D Henrion, J F Subra, L Loufrani, V Rohmer, N Ifrah, C Belizna.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：
Hydroxychloroquine

Year: 2013 PMID： 23902281 DOI： 10.1111/jth.12363

Source DB: PubMed Journal: J Thromb Haemost ISSN： 1538-7836 Impact factor: 5.824

Keyword Cloud
Cited

× No keyword cloud information.

29 in total

Review 1. Thrombosis and Anti-phospholipid Syndrome: a 5-Year Update on Treatment.

Authors: Cecilia Beatrice Chighizola; Pier Luigi Meroni
Journal: Curr Rheumatol Rep Date: 2018-05-31 Impact factor: 4.592

2. Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.

Authors: Entela Nuri; Mara Taraborelli; Laura Andreoli; Marta Tonello; Maria Gerosa; Antonia Calligaro; Lorenza Maria Argolini; Rajesh Kumar; Vittorio Pengo; Pier Luigi Meroni; Amelia Ruffatti; Angela Tincani
Journal: Immunol Res Date: 2017-02 Impact factor: 2.829

3. Platelet-derived extracellular vesicles released after trauma promote hemostasis and contribute to DVT in mice.

Authors: Mitchell R Dyer; Wyeth Alexander; Adnan Hassoune; Qiwei Chen; Tomasz Brzoska; Jurgis Alvikas; Yingjie Liu; Shannon Haldeman; Will Plautz; Patricia Loughran; Hui Li; Brian Boone; Yoel Sadovsky; Prithu Sundd; Brian S Zuckerbraun; Matthew D Neal
Journal: J Thromb Haemost Date: 2019-07-28 Impact factor: 5.824

4. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.

Authors: Ozan Unlu; Doruk Erkan; Medha Barbhaiya; Danieli Andrade; Iana Nascimento; Renata Rosa; Alessandra Banzato; Vittorio Pengo; Amaia Ugarte; Maria Gerosa; Lanlan Ji; Maria Efthymiou; D Ware Branch; Guilherme Ramires de Jesus; Angela Tincani; H Michael Belmont; Paul R Fortin; Michelle Petri; Esther Rodriguez; Guillermo J Pons-Estel; Jason S Knight; Tatsuya Atsumi; Rohan Willis; Stephane Zuily; Maria G Tektonidou
Journal: Arthritis Care Res (Hoboken) Date: 2019-01 Impact factor: 4.794

Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients.

Review 1. Thrombosis and Anti-phospholipid Syndrome: a 5-Year Update on Treatment.

2. Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.

3. Platelet-derived extracellular vesicles released after trauma promote hemostasis and contribute to DVT in mice.

4. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.

Review 5. Diagnosis and management of the antiphospholipid syndrome.

Review 6. Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage.

7. Is there a role for immunosuppression in antiphospholipid syndrome?

Review 8. Emerging Therapies in Antiphospholipid Syndrome.

Review 9. Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?

Review 10. The antiphospholipid syndrome: still an enigma.